Intracardiac thrombus formation with rapidly progressive heart failure in the neonate: treatment with tissue type plasminogen activator.
A newborn is described in whom the use of a central venous line was complicated by septicaemia and by intracardiac thrombus formation with tricuspid valve insufficiency and heart failure. Besides antibiotics, treatment consisted of tissue type plasminogen activator (tPA) for three days. This treatment resulted in the disappearance of the thrombus and the tricuspid insufficiency. No adverse effects were noted. Treatment with tPA should be considered in intracardiac thrombus formation with rapidly progressive heart failure in the neonate.
Van Overmeire
B
B
Department of Paediatrics, University Hospital, Antwerp, Belgium.
Van Reempts
P J
PJ
Van Acker
K J
KJ
D006328:Cardiac Catheterization / Q000009:adverse effects; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D013203:Staphylococcal Infections / Q000209:etiology; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014262:Tricuspid Valve Insufficiency / Q000188:drug therapy* / Q000209:etiology
D010959:Tissue Plasminogen Activator